Investor Relations


Accelerate Diagnostics Investor Information Center

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections. We are focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel™ platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity.

In addition to the BACcel system development pipeline, Accelerate Diagnostics also owns and licenses its propriety OptiChem® surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Our future investor relations section will offer a wealth of information regarding Accelerate’s performance to date and our strategy for the continued growth of our business. All of our SEC filings will be available, in addition to our recent announcements and presentations.

In the meantime, if you have questions or comments please contact our Investor Relations team at We will be happy to help!